Not investment advice.Read full disclaimer
Continue with finqOS
Side-by-side valuation, growth, and profitability metrics against the closest competitors.
14-day free trial · No credit card required
52W Range
Volume
Mkt Cap
P/E
Div Yield
Publicly traded Abbott India Limited (ABBOTINDIA.BO) competitors and peer companies. Compare valuation, revenue growth, margins, and profitability against Aurobindo Pharma Limited, Aurobindo Pharma Limited, Laurus Labs Limited, Alkem Laboratories Limited, Alkem Laboratories Limited, and more.
| Ticker | Company | Market Cap |
|---|---|---|
| AUROPHARMA.NS | Aurobindo Pharma Limited | $901.6B |
| AUROPHARMA.BO | Aurobindo Pharma Limited | $900.1B |
| LAURUSLABS.NS | Laurus Labs Limited | $808.0B |
| ALKEM.BO | Alkem Laboratories Limited | $661.6B |
| ALKEM.NS | Alkem Laboratories Limited | $656.2B |
| GLENMARK.BO | Glenmark Pharmaceuticals Limited | $620.7B |
| GLENMARK.NS | Glenmark Pharmaceuticals Limited | $620.2B |
| GLAND.BO | Gland Pharma Limited | $408.4B |
| GLAXO.BO | GlaxoSmithKline Pharmaceuticals Limited | $406.8B |
| GLAXO.NS | GlaxoSmithKline Pharmaceuticals Limited | $405.8B |